Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study

Atul T. Patel; Mark F. Lew; Khashayar Dashtipour; Stuart Isaacson; Robert A. Hauser; William Ondo; Pascal Maisonobe; Stefan Wietek; Bruce Rubin; Allison Brashear

doi:10.1371/journal.pone.0250475

Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study

Atul T. Patel, Mark F. Lew, Khashayar Dashtipour, Stuart Isaacson, Robert A. Hauser, William Ondo, Pascal Maisonobe, Stefan Wietek, Bruce Rubin, Allison Brashear

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

In Fig 2, the delta and p-value are missing for the last available post-baseline assessment. The missing information reflects a statistically significant difference in the mean TWSTRS total score of aboBoNT-A vs placebo at the last available data point. Please see the correct Fig 2 here. (Figure Presented).

Original language	English (US)
Article number	e0250475
Pages (from-to)	e0250475
Journal	PLoS ONE
Volume	16
Issue number	4
DOIs	https://doi.org/10.1371/journal.pone.0250475
State	Published - Apr 2021

ASJC Scopus subject areas

General

Access to Document

10.1371/journal.pone.0250475

Fingerprint

Dive into the research topics of 'Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study'. Together they form a unique fingerprint.

Cite this

Patel, A. T., Lew, M. F., Dashtipour, K., Isaacson, S., Hauser, R. A., Ondo, W., Maisonobe, P., Wietek, S., Rubin, B., & Brashear, A. (2021). Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study. PLoS ONE, 16(4), e0250475. Article e0250475. https://doi.org/10.1371/journal.pone.0250475

Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study. / Patel, Atul T.; Lew, Mark F.; Dashtipour, Khashayar et al.
In: PLoS ONE, Vol. 16, No. 4, e0250475, 04.2021, p. e0250475.

Research output: Contribution to journal › Article › peer-review

Patel, AT, Lew, MF, Dashtipour, K, Isaacson, S, Hauser, RA, Ondo, W, Maisonobe, P, Wietek, S, Rubin, B & Brashear, A 2021, 'Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study', PLoS ONE, vol. 16, no. 4, e0250475, pp. e0250475. https://doi.org/10.1371/journal.pone.0250475

Patel AT, Lew MF, Dashtipour K, Isaacson S, Hauser RA, Ondo W et al. Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study. PLoS ONE. 2021 Apr;16(4):e0250475. e0250475. doi: 10.1371/journal.pone.0250475

@article{7a0333d4369744e1aa88538b3fa771fc,

title = "Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study",

abstract = "In Fig 2, the delta and p-value are missing for the last available post-baseline assessment. The missing information reflects a statistically significant difference in the mean TWSTRS total score of aboBoNT-A vs placebo at the last available data point. Please see the correct Fig 2 here. (Figure Presented).",

author = "Patel, \{Atul T.\} and Lew, \{Mark F.\} and Khashayar Dashtipour and Stuart Isaacson and Hauser, \{Robert A.\} and William Ondo and Pascal Maisonobe and Stefan Wietek and Bruce Rubin and Allison Brashear",

note = "Publisher Copyright: {\textcopyright} 2021 Patel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.",

year = "2021",

month = apr,

doi = "10.1371/journal.pone.0250475",

language = "English (US)",

volume = "16",

pages = "e0250475",

journal = "PLoS ONE",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "4",

}

TY - JOUR

T1 - Correction

T2 - Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study

AU - Patel, Atul T.

AU - Lew, Mark F.

AU - Dashtipour, Khashayar

AU - Isaacson, Stuart

AU - Hauser, Robert A.

AU - Ondo, William

AU - Maisonobe, Pascal

AU - Wietek, Stefan

AU - Rubin, Bruce

AU - Brashear, Allison

N1 - Publisher Copyright: © 2021 Patel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PY - 2021/4

Y1 - 2021/4

N2 - In Fig 2, the delta and p-value are missing for the last available post-baseline assessment. The missing information reflects a statistically significant difference in the mean TWSTRS total score of aboBoNT-A vs placebo at the last available data point. Please see the correct Fig 2 here. (Figure Presented).

AB - In Fig 2, the delta and p-value are missing for the last available post-baseline assessment. The missing information reflects a statistically significant difference in the mean TWSTRS total score of aboBoNT-A vs placebo at the last available data point. Please see the correct Fig 2 here. (Figure Presented).

UR - https://www.scopus.com/pages/publications/85104152063

UR - https://www.scopus.com/inward/citedby.url?scp=85104152063&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0250475

DO - 10.1371/journal.pone.0250475

M3 - Article

C2 - 33852647

AN - SCOPUS:85104152063

SN - 1932-6203

VL - 16

SP - e0250475

JO - PLoS ONE

JF - PLoS ONE

IS - 4

M1 - e0250475

ER -

Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this